TG Therapeutics, Inc. (TGTX) Ownership

$43.44

south_east
-$1.93 (-4.25%)
Day's range
$42.96
Day's range
$45.97

TG Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/07/2025 21.90 M $659.15 M   -0.26% 15.09%
VANGUARD GROUP INC 02/11/2025 15.60 M $469.45 M   1.36% 10.75%
STATE STREET CORP 02/14/2025 9.20 M $276.92 M   1.16% 6.34%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 3.19 M $96.15 M   -0.37% 2.20%
PICTET ASSET MANAGEMENT HOLDING SA 02/12/2025 2.79 M $84.10 M   -22.01% 1.93%
SOLEUS CAPITAL MANAGEMENT, L.P. 02/14/2025 2.68 M $80.71 M   5.79% 1.85%
OPALEYE MANAGEMENT INC. 02/14/2025 2.26 M $68.03 M   -0.88% 1.56%
MORGAN STANLEY 02/14/2025 2.16 M $65.15 M   0.00% 1.49%
CLEARBRIDGE INVESTMENTS, LLC 02/12/2025 1.84 M $55.24 M   100.00% 1.26%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 1.80 M $54.15 M   -11.44% 1.24%
1832 ASSET MANAGEMENT L.P. 02/14/2025 1.66 M $49.82 M   100.00% 1.14%
GOLDMAN SACHS GROUP INC 02/11/2025 1.57 M $47.39 M   -38.42% 1.09%
NORTHERN TRUST CORP 02/14/2025 1.53 M $46.14 M   8.55% 1.06%
HOOD RIVER CAPITAL MANAGEMENT LLC 02/14/2025 1.46 M $43.81 M   -10.74% 1.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 1.27 M $38.35 M   51.98% 0.88%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/06/2025 1.27 M $38.21 M   7.17% 0.87%
FMR LLC 02/13/2025 1.03 M $31.05 M   -12.90% 0.71%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 997.80 K $30.03 M   1.94% 0.69%
SUVRETTA CAPITAL MANAGEMENT, LLC 02/14/2025 980.00 K $29.50 M   100.00% 0.68%
INVESCO LTD. 02/13/2025 929.74 K $27.99 M   1.20% 0.64%
BANK OF NEW YORK MELLON CORP 02/04/2025 923.49 K $27.80 M   10.49% 0.64%
PRINCIPAL FINANCIAL GROUP INC 01/31/2025 830.18 K $24.99 M   7.51% 0.57%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/14/2025 827.11 K $24.90 M   37.30% 0.57%
GROUP ONE TRADING, L.P. 02/14/2025 757.52 K $22.80 M   22.50% 0.52%
EVENTIDE ASSET MANAGEMENT, LLC 02/14/2025 718.81 K $21.64 M   0.00% 0.50%
683 CAPITAL MANAGEMENT, LLC 02/14/2025 697.00 K $20.98 M   -38.59% 0.48%
UBS GROUP AG 02/14/2025 647.10 K $19.48 M   -2.83% 0.45%
TWO SIGMA INVESTMENTS, LP 02/14/2025 606.21 K $18.25 M   -42.96% 0.42%
CITADEL ADVISORS LLC 02/14/2025 545.20 K $16.41 M   103.58% 0.38%
JANE STREET GROUP, LLC 02/14/2025 528.20 K $15.90 M   173.25% 0.36%
CITADEL ADVISORS LLC 02/14/2025 513.96 K $15.47 M   310.73% 0.35%
RAYMOND JAMES FINANCIAL INC 04/23/2025 481.99 K $14.51 M   100.00% 0.33%
AMERIPRISE FINANCIAL INC 02/14/2025 459.04 K $13.80 M   -0.07% 0.32%
ENSIGN PEAK ADVISORS, INC 02/14/2025 456.02 K $13.73 M   0.00% 0.31%
BRAUN STACEY ASSOCIATES INC 01/31/2025 442.81 K $13.33 M   100.00% 0.31%
JANE STREET GROUP, LLC 02/14/2025 439.20 K $13.22 M   40.05% 0.30%
NORGES BANK 02/12/2025 401.50 K $12.09 M   100.00% 0.28%
LEGAL & GENERAL GROUP PLC 02/13/2025 391.39 K $11.78 M   1.70% 0.27%
RHUMBLINE ADVISERS 01/30/2025 383.11 K $11.53 M   0.13% 0.26%
JPMORGAN CHASE & CO 02/12/2025 382.96 K $11.53 M   -46.87% 0.26%
PENN CAPITAL MANAGEMENT COMPANY, LLC 02/14/2025 351.41 K $10.58 M   100.00% 0.24%
CITIGROUP INC 02/12/2025 347.18 K $10.45 M   106.31% 0.24%
PUBLIC SECTOR PENSION INVESTMENT BOARD 02/14/2025 332.58 K $10.01 M   17.52% 0.23%
RAFFERTY ASSET MANAGEMENT, LLC 02/14/2025 331.41 K $9.98 M   -2.66% 0.23%
WELLS FARGO & COMPANY/MN 02/13/2025 331.40 K $9.98 M   85.43% 0.23%
CITADEL ADVISORS LLC 02/14/2025 324.90 K $9.78 M   -0.55% 0.22%
BARCLAYS PLC 02/13/2025 317.56 K $9.56 M   -8.50% 0.22%
NEW YORK STATE COMMON RETIREMENT FUND 01/31/2025 299.40 K $9.01 M   403.06% 0.21%
PRICE T ROWE ASSOCIATES INC /MD/ 02/14/2025 297.10 K $8.94 M   264.54% 0.20%
IKARIAN CAPITAL, LLC 02/14/2025 291.24 K $8.77 M   100.00% 0.20%

TG Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 343 institutional investors and hedge funds held shares of TG Therapeutics, Inc.. The most heavily invested institutionals were:

DiNuzzo Private Wealth, Inc.: 0

Bleakley Financial Group, LLC: 0

MISSION WEALTH MANAGEMENT, LP: 0

PSI Advisors, LLC: 0

Strategic Financial Concepts, LLC: 0

Precision Wealth Strategies, LLC: 0

66.76% of TG Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 88.95 M shares in the last 24 months. This purchase volume represents approximately $3.86 B in transactions.